| D007815 |
Larva Migrans |
Infections caused by nematode larvae which never develop into the adult stage and migrate through various body tissues. They commonly infect the skin, eyes, and viscera in man. Ancylostoma brasiliensis causes cutaneous larva migrans. Toxocara causes visceral larva migrans. |
Creeping Eruption,Cutaneous Larva Migrans,Larva Migrans, Cutaneous,Larva Migrans, Ocular,Ocular Larva Migrans,Dew Itch,Ground Itch,Creeping Eruptions,Dew Itchs,Eruption, Creeping,Eruptions, Creeping,Ground Itchs,Itch, Dew,Itch, Ground,Itchs, Dew,Itchs, Ground |
|
| D008297 |
Male |
|
Males |
|
| D002675 |
Child, Preschool |
A child between the ages of 2 and 5. |
Children, Preschool,Preschool Child,Preschool Children |
|
| D006801 |
Humans |
Members of the species Homo sapiens. |
Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man |
|
| D000969 |
Antinematodal Agents |
Substances used in the treatment or control of nematode infestations. They are used also in veterinary practice. |
Nematocides,Antinematodal Drugs,Antinematodals,Agents, Antinematodal,Drugs, Antinematodal |
|
| D000977 |
Antiparasitic Agents |
Drugs used to treat or prevent parasitic infections. |
Antiparasitic,Antiparasitic Agent,Antiparasitic Drug,Parasiticide,Parasiticides,Antiparasitic Drugs,Antiparasitics,Agent, Antiparasitic,Agents, Antiparasitic,Drug, Antiparasitic,Drugs, Antiparasitic |
|
| D012876 |
Skin Diseases, Parasitic |
Skin diseases caused by ARTHROPODS; HELMINTHS; or other parasites. |
Parasitic Skin Diseases,Disease, Parasitic Skin,Diseases, Parasitic Skin,Parasitic Skin Disease,Skin Disease, Parasitic |
|
| D013827 |
Thiabendazole |
2-Substituted benzimidazole first introduced in 1962. It is active against a variety of nematodes and is the drug of choice for STRONGYLOIDIASIS. It has CENTRAL NERVOUS SYSTEM side effects and hepatototoxic potential. (From Smith and Reynard, Textbook of Pharmacology, 1992, p919) |
Tiabendazol,2-(4'-Thiazolyl)Benzimidazole,Mintesol,Mintezol,Omnizole,Thibendole |
|
| D016896 |
Treatment Outcome |
Evaluation undertaken to assess the results or consequences of management and procedures used in combating disease in order to determine the efficacy, effectiveness, safety, and practicability of these interventions in individual cases or series. |
Rehabilitation Outcome,Treatment Effectiveness,Clinical Effectiveness,Clinical Efficacy,Patient-Relevant Outcome,Treatment Efficacy,Effectiveness, Clinical,Effectiveness, Treatment,Efficacy, Clinical,Efficacy, Treatment,Outcome, Patient-Relevant,Outcome, Rehabilitation,Outcome, Treatment,Outcomes, Patient-Relevant,Patient Relevant Outcome,Patient-Relevant Outcomes |
|